[1]
|
Hotta, N., Ayada, M., Okumura, A., Ishikawa, T. and Ka- kumu, S., (2007) Usefulness of live 3D echocardiography during radiofrequency ablation in a case of hepatocellular carcinoma. Clinical Imaging, 31, 283-286.
doi:10.1016/j.clinimag.2007.01.009
|
[2]
|
El-Serag, H.B. and Mason, A.C. (1999) Rising incidence of hepatocellular carci-noma in the United States. The New England Journal of Medi-cine, 340, 745-750.
doi:10.1056/NEJM199903113401001
|
[3]
|
Taylor-Robinson, S.D., Foster, G.R., Arora, S., Hargreaves, S. and Thomas, H.C. (1997) Increase in primary liver cancer in the UK 1979-94. Lancet, 350, 1142-1143.
doi:10.1016/S0140-6736(05)63789-0
|
[4]
|
Shiratori, Y., Shiina, S., Imamura, M., Kato, N., Knai, F., Okudaira T., Teratani, T., Tohgo, G., Toda, N. and Omata, M. (1995) Characteristic dif-ference of hepatocelluar carcinoma between hepatitis B- and C- viral infection in Japan. Hepatology, 22, 1027-1033.
doi:10.1002/hep.1840220403
|
[5]
|
Livraghi, T., Lazzaroni, S. and Meloni, F. (2001) Radiof- requency thermal ablation of hepatocellular carcinoma. European Journal of Ultarasound, 13, 159-166.
doi:10.1016/S0929-8266(01)00128-8
|
[6]
|
Hotta, N., Maeno, T., Ayada, M., Sato, K., Ishikawa, T., Okumura, A., Matsumoto, E., Fukuzawa, Y. and Kakumu, S. (2006) Four-dimensional ultrasonography for thera- peutic radiofrequency ablation for hepatocellular carcino- ma. Hepato-Gastroenterology, 53, 521-525.
|
[7]
|
Wen, L., Numata, K., Morimoto, M., Kondo, M., Takebayashi, S., Morita, S. and Tanaka, K. (2009) Focal Liver Tumors: Characterization with 3D perflubutane microbubble contrast agent; enhanced US versus 3D contrast- enhanced multidetector CT. Radiology, 251, 287-295.
doi:10.1148/radiol.2511081324
|
[8]
|
Numata, K., Luo, W., Morimoto, M., Kondom M., Ku- nishi, Y., Sasaki, T., Nozaki, A. and Tanaka, K. (2010) Contrast enhanced ultrasound of hepatocellular carcino- ma. World Journal of Radiology, 28, 68-82.
doi:10.4329/wjr.v2.i2.68
|